Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.6 GBX | +1.20% | +9.05% | +44.37% |
May. 01 | Renold gets GBP11 million contract with Royal Canadian Navy | AN |
May. 01 | GSK ups outlook; Next first-quarter beats forecast | AN |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Its low valuation, with P/E ratio at 6.45 and 6.67 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.58 for the 2024 fiscal year.
- The company has a low valuation given the cash flows generated by its activity.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+44.37% | 131M | - | ||
+12.62% | 82.74B | A- | ||
+17.86% | 69.97B | B | ||
+20.14% | 37.66B | B- | ||
+14.52% | 31.6B | A | ||
+12.35% | 27.79B | B- | ||
+2.46% | 26.5B | C+ | ||
+17.57% | 25.66B | B+ | ||
+2.11% | 25.43B | B+ | ||
+15.63% | 24.64B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- RNO Stock
- Ratings Renold plc